Cardiac medications list
Pro Research Analysisby 
Searched over 200M research papers
Essential Cardiac Medications List: Key Drug Classes and Examples
Cardiac medications are used to manage a wide range of cardiovascular diseases, including hypertension, heart failure, coronary artery disease, and arrhythmias. The most commonly prescribed classes of cardiac drugs include antiplatelets, diuretics, statins (lipid-lowering agents), calcium channel blockers, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin II receptor blockers (ARBs) 24.
Commonly Prescribed Cardiac Medications
- Antiplatelets: Aspirin is the most frequently prescribed antiplatelet, widely used to prevent blood clots in patients with cardiovascular disease .
- Diuretics: Furosemide and torsemide are common diuretics used to manage fluid overload in heart failure and hypertension 14.
- Statins: Rosuvastatin and other statins are used to lower cholesterol and reduce cardiovascular risk .
- Calcium Channel Blockers: Amlodipine is a typical example, used to treat hypertension and angina 24.
- Beta-Blockers: These drugs are important for managing hypertension, heart failure, and arrhythmias 24.
- ACE Inhibitors and ARBs: These are used for hypertension, heart failure, and to protect kidney function in certain patients 24.
- Anticoagulants: Warfarin and rivaroxaban are used to prevent blood clots, especially in patients with atrial fibrillation 18.
New and Emerging Heart Failure Medications
Recent advances have introduced new drug classes for heart failure, such as:
- Angiotensin–neprilysin inhibitors
- Sodium–glucose cotransporter-2 (SGLT2) inhibitors
- Oral soluble guanylate cyclase stimulators
These newer medications are now recommended in major heart failure guidelines and offer additional options for patients who do not respond to traditional therapies .
Essential Drug Lists and Prescribing Trends
National and international essential drug lists (EDLs) typically include a core set of cardiovascular medications, but local prescribing often expands beyond these lists. For example, the Indian National List of Essential Medicines (NLEM) includes 29 cardiovascular drugs, but in practice, up to 71 different cardiac medications may be prescribed in a tertiary care setting . Studies show that only about half of prescribed cardiac medications are on the essential drug list, and generic prescribing remains low .
Access, Availability, and Affordability of Cardiac Medications
Access to essential cardiac medications varies widely by country and income level. Generic medications are more available and affordable than brand-name drugs, but overall availability is still limited in many low- and middle-income countries. High costs and low availability are major barriers to effective cardiovascular disease management worldwide .
Special Considerations: Inappropriate Medications and Polypharmacy
Elderly patients and those with heart failure are at risk of being prescribed potentially inappropriate medications (PIMs), which can worsen outcomes or increase the risk of major adverse cardiac and cerebrovascular events. Tools and lists have been developed to help clinicians identify and avoid these medications in vulnerable populations 910. Polypharmacy, or the use of multiple medications, is common in cardiac patients and requires careful management to avoid drug interactions and adverse effects .
Digital Tools for Medication Management
Mobile apps with medication list functionalities can help patients, especially older adults with heart failure, keep track of their medications and share up-to-date lists with healthcare providers. However, the quality and usability of these apps vary, and only a few are based on scientific evidence .
Conclusion
The list of cardiac medications includes a range of drug classes such as antiplatelets, diuretics, statins, calcium channel blockers, beta-blockers, ACE inhibitors, ARBs, and newer agents for heart failure. While essential drug lists provide a foundation, real-world prescribing often includes additional medications. Access and affordability remain challenges, especially in lower-income settings. Careful management is needed to avoid inappropriate medications and polypharmacy, particularly in elderly and heart failure patients. Digital tools may support medication management, but their effectiveness depends on their quality and evidence base.
Sources and full results
Most relevant research papers on this topic